Regina Salvat, PhD, Partner, and Roberto Hofmann, PhD, Senior Analyst, will attend the 13th BioCentury-BayHelix China Healthcare Summit, taking place 2–4 November at The St. Regis Shanghai Jingan in Shanghai, China.
Regina will also be a panellist in the “Investors Roundtable: Beyond NewCo: Reinventing Venture Strategies for a New Era in Biopharma,” scheduled for 1:45–2:30 p.m. Asia Standard Time.
The summit brings together biotech executives, global pharmaceutical leaders, investors and industry partners to examine China’s rapidly evolving innovation ecosystem and explore developments in cross-border partnering, licensing and company creation.
The 13th China Healthcare Summit provides a leading platform to gain insight into China’s biotechnology landscape, build relationships with key industry decision-makers and explore opportunities shaping the future of healthcare innovation across China and the wider Asian market.